Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle. Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1327-01
Published May 29, 2013 · Recall initiated: April 1, 2013
Summary
FDA records drug Class II recall D-451-2013, published May 29, 2013 and initiated April 1, 2013. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 29,489 Bottles; Lot: Lot #: 1095923, Exp May-13; 1097828, Exp Jul-13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lloyd Inc. of Iowa
- Distributor
- The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.
- Lot
- Lot #: 1095923, Exp May-13; 1097828, Exp Jul-13.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDABudesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x 10 capsules blisterMay 29, 2013
Questions about this recall
Was Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle. Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1327-01 recalled?
Yes. FDA published recall D-451-2013 on May 29, 2013. Reported hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
What should I do if I have this product?
Voluntary: Firm initiated · Letter